T1	Participants 127 217	ocally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck.
T2	Participants 581 601	head and neck cancer
T3	Participants 614 732	130 patients with locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck (SCC H&N)
